Cos04 0007 01
Cosopt
Product Images NDC 17478-605
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cosopt (NDC 17478-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cos04 0007 02
Cos04 0007 03
Cos04 0007 04
Cos04 0007 05
COSOPT is an ophthalmic solution used for topical application in the eye. It contains dorzolamide hydrochloride and timolol maleate in a concentration of 2% and 0.5% respectively. Each mL of COSOPT contains 22.3mg of dorzolamide hydrochloride equivalent to 20mg of dorzolamide and 6.8mg of timolol maleate equivalent to 5mg of timolol. Usual dosage instructions can be found in the package insert. COSOPT is to be stored between 20°C to 25°C and protected from light. It is distributed by Akorn Inc. and made in Switzerland.*
Cos04 0007 06
This is a description of the ophthalmic solution medication called "COSOPT". It contains dorzolamide hydrochloride and timolol maleate and is used for topical application in the eye. The usual dosage instructions can be found in the package insert. The medication should be stored at 20-25°C and protected from light. The product is sterile when manufactured and has a preservative called benzalkonium chloride. The solution should be dispensed in the original unopened container and patients should be instructed on precautions to avoid contamination. The medication is distributed by Akorn, Inc. in Lake Forest, IL, and the trademark is owned by Merck Sharp & Dohme Corp. The package contains 10 mL of the solution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
